ISCT Webinar featuring Farzin Farzaneh, PhD, FRCPath, FRSB – Dec 6, 2023

Wed, Dec 6, 2023 – 09:00 PST | 12:00 EST | 17:00 GMT | 18:00 CET

Critical Factors to Assess When Sourcing Viral or Non-Viral Engineering CMOs for Gene-Modified Therapies

with CHAIR:

Jeff Liter, MBA – CEO, Luminary Therapeutics, USA

SPEAKERS:

Farzin Farzaneh, PhD, FRCPath, FRSB – Chief Scientific Offer, ViroCell Biologics, UK

Professor of Molecular Medicine, School of Cancer & Pharmaceutical Sciences, King’s College London

David Hermanson, PhD – Director of Cell and Gene Therapy Applications, Bio-Techne, USA